过敏性疾病63例生物共振脱敏效果观察

目的观察生物共振治疗系统对过敏性疾病进行脱敏治疗的效果。方法应用生物共振治疗仪对135例过敏性疾病患者进行过敏原测定,并对其中63例进行系统的脱敏治疗。结果63例患者脱敏治疗的总优良率为82.5%。变应性皮炎、过敏性鼻炎、过敏性哮喘三组比较差异无统计学意义(P>0.05)。单纯变应性皮炎较单纯变应性皮炎合并其他过敏症患者的疗效显著(P<0.01)。结论生物共振脱敏治疗无任何不良反应,是一种比较理想的过敏性疾病的治疗方法。     

Late-onset and Recurrent Neonatal Group B Streptococcal Disease Associated with Breast-milk Transmission

The purpose of the study was to determine the epidemiological relationships in three unrelated cases of neonatal late-onset Group B streptococcal (GBS) disease and maternal breast-milk infection with GBS. All deliveries were by cesarean section; case 1 was at term, and cases 2 and 3 were at 32- and 33-wk gestation, respectively. Case 1 relates to a mother with clinical mastitis and recurrent GBS infection in a 20-day-old male infant. Following antibiotic therapy and cessation of breast-feeding, the infant recovered without sequelae. Case 2 refers to a mother with clinical mastitis and the occurrence of late-onset GBS disease in 5-wk-old male twins. Despite intervention, one infant died and the second became ill. Following antibiotic therapy and cessation of breast-feeding, the surviving infant recovered without sequelae. Case 3 refers to a mother with sub-clinical mastitis and late-onset GBS infection occurring in a 6-day-old female twin. Following intervention, the infant recovered but suffered a bilateral thalamic infarction resulting in developmental delay and a severe seizure disorder. Following recovery of GBS from an inapparent mastitis and cessation of breast-feeding, the second infant remained well. Blood cultures from all affected infants and maternal breast milk were positive for GBS. Epidemiological relationships between neonatal- and maternal-derived GBS isolates were confirmed by a random amplified polymorphic DNA polymerase chain reaction assay (RAPD-PCR). This study is significant in that it has demonstrated that maternal milk (in cases of either clinical or sub-clinical mastitis) can be a potential source of infection resulting in either late-onset or recurrent neonatal GBS disease.     

Closure of a large bronchial fistula with a latissimus dorsi myocutaneous flap

We describe a case of a large bronchial fistula and empyema after right upper lobectomy that was treated successfully with open window thoracostomy followed by a latissimus dorsi myocutaneous flap and limited thoracoplasty. A latissimus dorsi myocutaneous flap can provide immediate airtight closure of a large bronchial fistula, allowing lavage and curettage of the empyema cavity to reduce the chance of postoperative infection. An important aspect of this technique is that the deepithelialized skin side rather than muscle is sutured to an opening of the bronchus. As compared with other techniques, a latissimus dorsi myocutaneous flap is superior in that it requires a single incision and does not require an intraop-erative change of position. In addition, the technique causes little dysfunction of the chest and shoulder and preserves the vascular supply to ensure the viability of the flap even if it was divided in a previous operation.     

对胡永才虚假文章的剖析

目的：揭露胡永才虚假文章的事实真相,消除负面影响。方法：对“湿润烧伤膏治疗烧伤总面积＞50%TBSA患者的疗效观察”一文的课题设计、处理因素、效应指标、统计方法及论文写作等内容进行全面剖析。结果：课题设计违背了科研原则,观察组与对照组处理因素随意性太大,效应指标缺乏可信性,诊断依据不标准,统计学概念不清,论文写作不规范。结论：论文内容失真,不能代表总体样本真实情况。     

Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea

Background  

Glioblastoma multiforme is the most malignant form of brain tumor. Despite treatment including surgical resection, adjuvant chemotherapy, and radiation, these tumors typically recur. The recurrent tumor is often resistant to further therapy with the same agent, suggesting that the surviving cells that repopulate the tumor mass have an intrinsic genetic advantage. We previously demonstrated that cells selected for resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) are near-diploid, with over-representation of part or all of chromosomes 7 and 22. While cells from untreated gliomas often have over-representation of chromosome 7, chromosome 22 is typically under-represented.     

通过三年资料实证医院检验科常规项目全成本

目的弄清医院常规检验项目的实际成本,为医院及卫生主管部门进行科学管理和政府物价部门制订科学合理的收费价格体系提供科学依据。方法对某二级甲等医院检验科3年中所开展的全部7大类16个项目组169个检验项目的成本按耗材、设备折旧、劳务费、房屋折旧、业务费与后勤管理费共5大类进行实证分析。结果该科的成本构成比是:耗材成本34.1%、设备折旧24.3%、劳务费30.0%、房屋折旧4.0%、业务费与后勤管理费7.6%;检验项目的每项次平均成本为7.17元;成本最低的两类检验项目是生化及定性免疫,其项次成本分别为3.18元和4.25元;最高的则为微生物和血库,项次成本分别为48.63元和35.21元;项次成本过百元的有7项,多为输血项目;5至10倍于平均成本的28项,2至5倍于全科平均成本的22项,其余112项介于全科平均成本上下。结论实证研究是准确掌握检验项目成本的有效方法。